导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 19.04% | 211/1050 |
| 近一周 | -1.42% | 197/1104 |
| 近一月 | -1.27% | 167/1102 |
| 近一季 | 3.39% | 145/1092 |
| 近半年 | 8.33% | 269/1070 |
| 近一年 | 29.78% | 161/1018 |
| 近两年 | 125.46% | 136/926 |
| 近三年 | 77.62% | 131/834 |
| 成立以来 | 379.10% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
5.34% 133/1070 |
11.52% 526/1101 |
- - |
- - |
| 2025 | 40.28% 322/1065 |
4.34% 456/1014 |
-1.63% 820/1038 |
29.97% 358/1050 |
5.16% 133/1065 |
| 2024 | 4.72% 435/1011 |
-8.96% 741/960 |
-8.44% 805/983 |
19.12% 84/991 |
5.46% 122/1011 |
| 2023 | -14.07% 483/952 |
4.66% 346/880 |
-11.01% 790/895 |
-10.10% 591/915 |
2.63% 51/952 |
| 2022 | -19.19% 300/867 |
-17.97% 424/773 |
11.64% 202/806 |
-16.86% 676/845 |
6.15% 160/867 |
| 2021 | 29.40% 74/740 |
-1.63% 209/580 |
18.87% 172/659 |
2.46% 177/704 |
8.01% 127/740 |
| 2020 | 54.49% 219/554 |
2.39% 105/419 |
19.05% 303/466 |
13.58% 169/517 |
11.59% 307/554 |
| 2019 | 49.09% 154/410 |
29.08% 424/1149 |
-5.83% 766/1231 |
8.43% 141/390 |
13.12% 92/410 |
| 2018 | -24.57% 138/349 |
- - |
- - |
- - |
-9.41% 252/1080 |
| 2017 | 5.20% 156/285 |
- - |
- - |
- - |
- - |
| 2016 | 5.86% 15/205 |
- - |
- - |
- - |
- - |
| 2015 | 70.02% 8/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 大摩品质生活精选股票A VS. 东吴新产业精选股票A(580008) |